More Articles

Forest Labs files lawsuit to stop generic memantine Generics/News | Posted 07/02/2014

Forest Laboratories and Forest Laboratories Holdings (Forest) announced on 31 January 2014 that the company has filed a lawsuit in the US against several generics makers for their generic versions...

Biosimilars: what physicians need to know Reports | Posted 07/02/2014

A biosimilar is a medicinal product that is similar to a biological medicinal product that has already been authorized. Biologicals are comprised of proteins, such as hormones (growth hormones, ins...

Epirus and Ranbaxy sign agreement for infliximab 'similar biologic' Biosimilars/News | Posted 07/02/2014

Epirus Switzerland, a subsidiary of US-based Epirus Biopharmaceuticals, and India-based Ranbaxy Laboratories (Ranbaxy) announced on 9 January 2013 that the two companies had signed a licensing agre...

Improving access to HCV treatment in developing countries Biosimilars/Research | Posted 31/01/2014

Hepatitis C virus (HCV) infection affects 150–180 million people worldwide each year, killing an estimated 350,000. The considerable cost of treatment – US$ 10,000–US$20,000 per patient for a 48-we...

Biologicals sales quadruple from 2002 to 2017 Biosimilars/General | Posted 31/01/2014

Biologicals are outstripping regular pharmaceuticals in terms of growth and taking a bigger and bigger chunk of overall drug sales. Increasingly, biosimilars and non-originator biologicals are also...

Access to medicines in Shaanxi province China Generics/Research | Posted 31/01/2014

Although generics in the Shaanxi province of China are significantly cheaper than their brand-name equivalents there is still room for improvement, according to a study of the prices and availabili...

Subsequent entry biologics approved in Canada Biosimilars/General | Posted 31/01/2014

Last update: 7 October 2016 In Canada, the regulatory body for the approval of biologicals is the Biologics and Genetic Therapies Directorate (BGTD) of the Health Products and Food Branch (HPF...

Giving EU Member States more freedom could increase early access to new drugs Reports | Posted 31/01/2014

A UK report urges giving European Union (EU) Member States greater freedoms to determine their own policies with respect to data protection and early access to medical innovations [1].